Private Wealth Management
For a broader glimpse of key investment sectors to watch in 2021, William Blair analysts share their thoughts on renewable energy/climate, infrastructure, healthcare, and technology in Client Focus.
Additionally, the head of our biotech equity research team provides the latest developments from Pfizer, Moderna, and other vaccine candidates along with an approximate timeline for rollouts.
Stay up-to-date with the latest William Blair news and insights
William Blair initiated research coverage of First Advantage Corporation (FA $15.32), a leading global provider of technology-enabled background screening products.
Read moreWilliam Blair acted as the exclusive financial advisor to Nehring Electrical Works Company in connection with its pending sale to Mueller Industries, Inc.
Read moreWilliam Blair acted as the exclusive financial advisor to Nothum Food Processing Solutions in connection with its sale to Fortifi Food Processing Solutions, a KKR portfolio company.
Read moreInformation contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
